Curvebeam Ai Ltd - Asset Resilience Ratio

Latest as of June 2025: 8.27%

Curvebeam Ai Ltd (CVB) has an Asset Resilience Ratio of 8.27% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$5.04 Million

≈ $3.57 Million USD Cash + Short-term Investments

Total Assets

AU$60.98 Million

≈ $43.15 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how Curvebeam Ai Ltd's Asset Resilience Ratio has changed over time. Check CVB strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Curvebeam Ai Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Curvebeam Ai Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$5.04 Million	8.27%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$5.04 Million	8.27%

Asset Resilience Insights

Limited Liquidity: Curvebeam Ai Ltd maintains only 8.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Curvebeam Ai Ltd Industry Peers by Asset Resilience Ratio

Compare Curvebeam Ai Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Curvebeam Ai Ltd (2023–2025)

The table below shows the annual Asset Resilience Ratio data for Curvebeam Ai Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	8.27%	AU$5.04 Million ≈ $3.57 Million	AU$60.98 Million ≈ $43.15 Million	-1.92pp
2024-06-30	10.18%	AU$6.45 Million ≈ $4.56 Million	AU$63.33 Million ≈ $44.81 Million	+1.78pp
2023-06-30	8.41%	AU$5.16 Million ≈ $3.65 Million	AU$61.36 Million ≈ $43.42 Million	--

pp = percentage points

About Curvebeam Ai Ltd

AU:CVB Australia Medical Devices

Market Cap

$6.42 Million

AU$9.08 Million AUD

Market Cap Rank

#28052 Global

#1449 in Australia

Share Price

AU$0.02

Change (1 day)

+5.56%

52-Week Range

AU$0.02 - AU$0.18

All Time High

AU$0.50